Security key
67577R102
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD)
CUSIP: 67577R102
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 17,503,196
- Total 13F value
- $16,482,508
- Share change
- +2,942,885
- Put/Call ratio
- 0%
- SEC-reported price per share
- $0.94
- Number of holders
- 43
- Value change
- +$2,741,389
- Number of buys
- 16
- Number of sells
- 17
- Shares outstanding
- 83,247,726
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
43
Top holders
10
IRD full security history
Ownership snapshot
Full 13F holder table
Opus Genetics, Inc. SEC filings
Opus Genetics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BIOS Fund III, LP
Disclosed value leader
BIOS Fund III, LP
Comparable rows
15/15
Latest evidence
05 May 2025
13D/G
13F
Lead comparable stake: 6.2%
13D/G row: BIOS Fund III, LP
Showing 1-6 of 15 holder rows.
Quick read
BIOS Fund III, LP leads the comparable SEC ownership view at 6.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BIOS Fund III, LP's linked filing trail.
Comparable ownership
Top 5
BIOS Fund III, LP
6.2%
PERCEPTIVE ADVISORS LLC
5.2%
Nantahala Capital Management, LLC
3.8%
Opaleye Management Inc.
1.4%
Mink Brook Asset Management LLC
0.97%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BIOS Fund III, LP |
13D/G
BIOS EQUITY PARTNERS III, LP
|
6.2%
|
$5,156,801
3,683,429 shares
|
$0 | 05 May 2025 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
5.2%
|
$4,246,285
4,325,000 shares
|
— | 31 Mar 2025 |
| Nantahala Capital Management, LLC |
13F
Company
|
3.8%
|
$3,100,421
3,157,895 shares
|
— | 31 Mar 2025 |
| Opaleye Management Inc. |
13F
Company
|
1.4%
|
$1,546,335
1,175,000 shares
|
— | 31 Mar 2025 |
| Mink Brook Asset Management LLC |
13F
Company
|
0.97%
|
$795,337
810,080 shares
|
— | 31 Mar 2025 |
| Bleichroeder LP |
13F
Company
|
0.89%
|
$723,431
736,842 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
43
Shares
17,503,196
Rows available
43
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
46
Q2 2025 holders
43
Holder diff
-3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|